Stay updated on ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:13:42.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the ClinicalTrials.gov page, which still shows a 403 Forbidden error instead of the study record.
    Difference
    1%
    Check dated 2026-10-25T15:27:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T21:00:27.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T21:52:53.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 is added to the page. A large set of study documents and related items, including Informed Consent Form entries and the Study Protocol/SAP, were removed from the Study Documents section.
    Difference
    18%
    Check dated 2026-09-20T19:25:39.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page metadata now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a small release version update.
    Difference
    0.1%
    Check dated 2026-08-30T15:38:06.000Z thumbnail image

Stay in the know with updates to ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.